Demir S, Nawroth PP, Herzig S, Ekim Ustunel B. Emerging targets in type 2 diabetes and diabetic complications. Adv Sci (Weinh). 2021;8:e2100275.

Article  PubMed  Google Scholar 

Kumar V, Xin X, Ma J, Tan C, Osna N, Mahato RI. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Adv Drug Deliv Rev. 2021;176:113888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paternostro R, Trauner M. Current treatment of non-alcoholic fatty liver disease. J Intern Med. 2022;292:190–204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18:599–612.

Article  PubMed  Google Scholar 

Cusi K. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. Diabetologia. 2016;59:1112–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10:284–96.

Article  PubMed  Google Scholar 

Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054–81.

Article  CAS  PubMed  Google Scholar 

Wu Q, Huang F. Targeting ferroptosis as a prospective therapeutic approach for diabetic nephropathy. Ann Med. 2024;56:2346543.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Zhao W, Hu A, Lin S, Chen P, Yang B, et al. Type 2 diabetic mellitus related osteoporosis: focusing on ferroptosis. J Transl Med. 2024;22:409.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng X, Tan Y, Li H, Zhang Z, Hui S, Zhang Z. et al. Mechanistic insights and potential therapeutic implications of NRF2 in diabetic encephalopathy. Mol Neurobiol. 2024;61:8253–78.

Article  CAS  PubMed  Google Scholar 

Song Z, Wang J, Zhang L. Ferroptosis: a new mechanism in diabetic cardiomyopathy. Int J Med Sci. 2024;21:612–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li SY, Zhao N, Wei D, Pu N, Hao XN, Huang JM, et al. Ferroptosis in the ageing retina: A malevolent fire of diabetic retinopathy. Ageing Res Rev. 2024;93:102142.

Article  CAS  PubMed  Google Scholar 

Feng G, Byrne CD, Targher G, Wang F, Zheng MH. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link? Liver Int. 2022;42:1496–502.

Article  PubMed  Google Scholar 

Stancic A, Velickovic K, Markelic M, Grigorov I, Saksida T, Savic N, et al. Involvement of ferroptosis in diabetes-induced liver pathology. Int J Mol Sci.2022;23:9309.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo T, Yan W, Cui X, Liu N, Wei X, Sun Y, et al. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis. Mol Med. 2023;29:132.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang M, Xia L, Song J, Hu H, Zang N, Yang J, et al. Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation. Lipids Health Dis. 2023;22:202.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang T, Wang MY, Wang GD, Lv QY, Huang YQ, Zhang P, et al. Metformin improves nonalcoholic fatty liver disease in db/db mice by inhibiting ferroptosis. Eur J Pharmacol. 2024;966:176341.

Article  CAS  PubMed  Google Scholar 

Savic N, Markelic M, Stancic A, Velickovic K, Grigorov I, Vucetic M, et al. Sulforaphane prevents diabetes-induced hepatic ferroptosis by activating Nrf2 signaling axis. Biofactors. 2024;50:810–27.

Article  CAS  PubMed  Google Scholar 

Gong Y, Liu Z, Zhang Y, Zhang J, Zheng Y, Wu Z. AGER1 deficiency-triggered ferroptosis drives fibrosis progression in nonalcoholic steatohepatitis with type 2 diabetes mellitus. Cell Death Discov. 2023;9:178.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olsson M, Lindahl G, Ruoslahti E. Genetic control of alpha-fetoprotein synthesis in the mouse. J Exp Med. 1977;145:819–27.

Article  CAS  PubMed  Google Scholar 

Perincheri S, Dingle RW, Peterson ML, Spear BT. Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB/cJ mice is due to a retrovirus insertion in the Zhx2 gene. Proc Natl Acad Sci USA. 2005;102:396–401.

Article  CAS  PubMed  Google Scholar 

Peterson ML, Ma C, Spear BT. Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer. Semin Cancer Biol. 2011;21:21–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luan F, Liu P, Ma H, Yue X, Liu J, Gao L, et al. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma. Int J Biochem Cell Biol. 2014;55:129–35.

Article  CAS  PubMed  Google Scholar 

Wu Z, Ma H, Wang L, Song X, Zhang J, Liu W, et al. Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake. Cell Death Differ. 2020;27:1693–708.

Article  CAS  PubMed  Google Scholar 

Zhao Y, Gao L, Jiang C, Chen J, Qin Z, Zhong F, et al. The transcription factor zinc fingers and homeoboxes 2 alleviates NASH by transcriptional activation of phosphatase and tensin homolog. Hepatology. 2022;75:939–54.

Article  CAS  PubMed  Google Scholar 

Miao R, Fang X, Zhang Y, Wei J, Zhang Y, Tian J. Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities. Cell Death Dis. 2023;14:186.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Zhou X, Wang X. m(6)A binding protein YTHDF2 in cancer. Exp Hematol Oncol. 2022;11:21.

Article  PubMed  PubMed Central  Google Scholar 

Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X, et al. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression. J Exp Clin Cancer Res. 2024;43:108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. 2017;66:241–55.

Article  CAS  PubMed  Google Scholar 

Collaborators GBDD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203–34.

Article  Google Scholar